Senna Safety To Be Studied By Purdue, Madaus, Novartis, Reckitt & Colman
This article was originally published in The Tan Sheet
Executive Summary
Laxative product manufacturer Purdue Pharma (Senokot) is working with Madaus AG (Agiolax), Novartis Consumer Health (Ex-Lax) and Reckitt & Colman (Senokot overseas) to "comparatively analyze" natural senna as well as sennoside laxative active ingredients, Purdue told FDA in a June 30 letter made available recently. The firm had agreed to conduct a two-year safety study on the laxative ingredient in a Sept. 3 letter to the agency (1"The Tan Sheet" Sept. 28, 1998, In Brief).
You may also be interested in...
Agoral Laxative With Senna Being Relaunched By Numark Labs
Numark Laboratories is introducing reformulated Agoral liquid laxative in the U.S. and Canada under a licensing agreement with Warner-Lambert. The new product is formulated with the active ingredient senna extract containing sennosides USP 25 mg.
Agoral Laxative With Senna Being Relaunched By Numark Labs
Numark Laboratories is introducing reformulated Agoral liquid laxative in the U.S. and Canada under a licensing agreement with Warner-Lambert. The new product is formulated with the active ingredient senna extract containing sennosides USP 25 mg.
Agoral Laxative With Senna Being Relaunched By Numark Labs
Numark Laboratories is introducing reformulated Agoral liquid laxative in the U.S. and Canada under a licensing agreement with Warner-Lambert. The new product is formulated with the active ingredient senna extract containing sennosides USP 25 mg.